Getting personal with melanoma.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 21712453.
- Also identified by DOI 10.1158/1078-0432.CCR-11-0841 and PMC identifier 3131472.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Long-term follow-up of patients with metastatic melanoma who received adoptive immunotherapy with autologous tumor infiltrating lymphocytes shows that patients who attained complete remission had durable responses, with 19 of 20 such patients remaining in remission from 3 to 7 years or more.
Medical subject headings
- Immunotherapy, Adoptive
- Lymphocytes, Tumor-Infiltrating
- Melanoma